Pirfenidone-d3 is a deuterated form of pirfenidone, a compound primarily used in the treatment of idiopathic pulmonary fibrosis (IPF). The deuteration, indicated by the "d3" in its name, refers to the substitution of three hydrogen atoms with deuterium, a heavier isotope of hydrogen. This modification can enhance the stability and metabolic tracking of the compound in biological studies. Pirfenidone itself is known for its antifibrotic and anti-inflammatory properties, acting through multiple pathways to reduce fibrosis in lung tissue. The chemical structure of pirfenidone-d3 retains the core characteristics of pirfenidone, including its ability to inhibit fibroblast proliferation and collagen synthesis. Its pharmacokinetic properties may differ slightly from the non-deuterated version, potentially affecting its absorption, distribution, metabolism, and excretion. Pirfenidone-d3 is primarily utilized in research settings to study the drug's mechanisms of action and its effects in various biological systems, providing insights into its therapeutic potential and safety profile.

Pirfenidone-d3

1093951-85-9: Pirfenidone-d3 is a deuterated form of pirfenidone, a compound primarily used in the treatment of idiopathic pulmonary fibrosis (IPF). The deuteration, indicated by the "d3" in its name, refers to the substitution of three hydrogen atoms with deuterium, a heavier isotope of hydrogen. This modification can enhance the stability and metabolic tracking of the compound in biological studies. Pirfenidone itself is known for its antifibrotic and anti-inflammatory properties, acting through multiple pathways to reduce fibrosis in lung tissue. The chemical structure of pirfenidone-d3 retains the core characteristics of pirfenidone, including its ability to inhibit fibroblast proliferation and collagen synthesis. Its pharmacokinetic properties may differ slightly from the non-deuterated version, potentially affecting its absorption, distribution, metabolism, and excretion. Pirfenidone-d3 is primarily utilized in research settings to study the drug's mechanisms of action and its effects in various biological systems, providing insights into its therapeutic potential and safety profile.

CAS 1093951-85-9

Pirfenidone-d3